A research work conducted by Li et al. explored the chemopreventive role of fisetin bioactive compound against nasopharyngeal carcinoma (NPC) cells through the suppression of the survival rate of CNE‐latent membrane protein 1 (LMP1) cells and NF‐κB activation, preventing the nuclear translocation of NF‐κB (p65) and IκBα phosphorylation as well as suppressing the cyclin D1 expressions. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.